• Wiley Online Library will be disrupted on 26 May from 10:00-12:00 BST (05:00-07:00 EDT) for essential maintenance

Chapter 13. LMNA Mutations in Progeroid Syndromes

  1. Derek J. Chadwick Organizer,
  2. Jamie Goode
  1. Shurong Huang1,
  2. Brian K. Kennedy3,
  3. Junko Oshima2,*

Published Online: 7 OCT 2008

DOI: 10.1002/0470093765.ch13

Nuclear Organization in Development and Disease: Novartis Foundation Symposium 264

Nuclear Organization in Development and Disease: Novartis Foundation Symposium 264

How to Cite

Huang, S., Kennedy, B. K. and Oshima, J. (2008) LMNA Mutations in Progeroid Syndromes, in Nuclear Organization in Development and Disease: Novartis Foundation Symposium 264 (eds D. J. Chadwick and J. Goode), John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/0470093765.ch13

Author Information

  1. 1

    Department of Pathology and Department of Biochemistry, University of Washington, Box 357470, Seattle, WA 98195, USA

  2. 2

    Department of Pathology and Department of Biochemistry, Box 357470, Health Sciences Building, Room K-543B, University of Washington School of Medicine, 1959 NE Pacific Avenue, Seattle, WA 98195-7470, USA

  3. 3

    Department of Biochemistry, University of Washington, Seattle, WA 98195, USA

*Department of Pathology and Department of Biochemistry, Box 357470, Health Sciences Building, Room K-543B, University of Washington School of Medicine, 1959 NE Pacific Avenue, Seattle, WA 98195-7470, USA

Publication History

  1. Published Online: 7 OCT 2008
  2. Published Print: 14 JAN 2005

Book Series:

  1. Novartis Foundation Symposia

Book Series Editors:

  1. Novartis Foundation

ISBN Information

Print ISBN: 9780470093733

Online ISBN: 9780470093764

SEARCH

Keywords:

  • segmental progeroid syndromes;
  • Hutchinson-Gilford progeria syndrome (HGPS);
  • Werner syndrome (WS);
  • altered chromatin silencing;
  • LMNA mutations;
  • immunolocalization;
  • Santa Cruz antibody;
  • apoptosis and Werner's cells;
  • common age-related disorders

Summary

Segmental progeroid syndromes are disorders in which affected individuals present various features that suggest accelerated ageing. The two best-known examples are Hutchinson-Gilford progeria syndrome (HGPS, ‘Progeria of childhood’) and Werner syndrome (WS, ‘Progeria of the adult’). A novel, recurrent de novo mutation in the LMNA gene, responsible for the majority of HGPS cases, results in an in-frame deletion of 50 amino acids, including endoproteolytic sites required for processing of prelamin A to mature lamin A protein. Another mutation results in a 35 amino acid inframe deletion with a milder HGPS phenotype. WRN, the gene responsible for the majority of WS cases, encodes a multifunctional nuclear protein with exonuclease and helicase activities and may participate in optimizing DNA repair/recombination. A subset of WS patients do not show mutations at the WRN locus (atypical WS), but show heterozygous amino acid substitutions in the heptad repeat region of lamin A. Structural analysis suggests that mutations in atypical WS may interfere with protein protein interactions. When compared to WRN-mutant WS, LMNA-mutant atypical WS patients appear to show earlier onset and possibly more severe ageing-related symptoms.